Novartis AG Operating Income 2010-2024 | NVS

Novartis AG operating income for the twelve months ending June 30, 2024 was $11.731B, a 41.49% increase year-over-year.

  • Novartis AG annual operating income for 2023 was $9.769B, a 22.94% increase from 2022.
  • Novartis AG annual operating income for 2022 was $7.946B, a 32.02% decline from 2021.
  • Novartis AG annual operating income for 2021 was $11.689B, a 15.14% increase from 2020.

Novartis AG Operating Income 2010-2024 | NVS

  • Novartis AG annual operating income for 2023 was $9.769B, a 22.94% increase from 2022.
  • Novartis AG annual operating income for 2022 was $7.946B, a 32.02% decline from 2021.
  • Novartis AG annual operating income for 2021 was $11.689B, a 15.14% increase from 2020.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$495.1B
Johnson & Johnson (JNJ)$450.1B
Novo Nordisk (NVO)$424.5B
Merck (MRK)$270B
AbbVie (ABBV)$264.1B
AstraZeneca (AZN)$218.5B
Pfizer (PFE)$201.2B
Sanofi (SNY)$133B
Innoviva (INVA)$953M